Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/02/2018 → 23/12/2022 |
Funding
- IGEM Therapeutics Ltd: £533,957.00
- IGEM Therapeutics Ltd: £794,842.00
- IGEM Therapeutics Ltd: £73,829.70
IgE antibodies in cancer
- Karagiannis, Sophia (Primary Investigator)
Project: Research